Edition:
United Kingdom

Cadila Healthcare Ltd (CADI.NS)

CADI.NS on National Stock Exchange of India

411.20INR
15 Dec 2017
Change (% chg)

Rs1.55 (+0.38%)
Prev Close
Rs409.65
Open
Rs415.00
Day's High
Rs418.00
Day's Low
Rs408.50
Volume
1,041,283
Avg. Vol
1,145,460
52-wk High
Rs560.00
52-wk Low
Rs328.80

Latest Key Developments (Source: Significant Developments)

Cadila Healthcare Says ‍Zydus Got USFDA Nod For Two Drugs
Thursday, 14 Dec 2017 

Dec 14 (Reuters) - Cadila Healthcare Ltd ::‍ZYDUS GETS FINAL APPROVAL FROM USFDA FOR PRAMIPEXOLE DIHYDROCHLORIDE EXTENDED-RELEASE TABLETS & NITROFURANTOIN CAPSULES USP (MACROCRYSTALS)​.PRAMIPEXOLE DIHYDROCHLORIDE TO TREAT SYMPTOMS OF PARKINSON'S DISEASE; NITROFURANTOIN TO TREAT ACUTE URINARY TRACT INFECTION.SAYS BOTH DRUGS TO BE MANUFACTURED AT CO'S FORMULATIONS MANUFACTURING FACILITY AT MORAIYA, AHMEDABAD‍​.  Full Article

Cadila Healthcare's Zydus Gets Final Nod From U.S. FDA For Clozapine Tablets
Friday, 8 Dec 2017 

Dec 8 (Reuters) - Cadila Healthcare Ltd ::SAYS ZYDUS GET FINAL NOD FROM U.S. FDA FOR CLOZAPINE TABLETS USP.DRUG USED TO TREAT SCHIZOPHRENIA ; DRUG TO BE MANUFACTURED AT GROUP'S FORMULATIONS MANUFACTURING FACILITY AT AHMEDABAD.  Full Article

Cadila Healthcare Says Zydus Gets Tentative Approval From U.S. FDA For Pregabalin Capsules
Friday, 1 Dec 2017 

Dec 1 (Reuters) - Cadila Healthcare Ltd ::SAYS ZYDUS GETS TENTATIVE APPROVAL FROM U.S. FDA FOR PREGABALIN CAPSULES.SAYS CAPSULE TO BE MANUFACTURED AT GROUP'S FORMULATIONS FACILITY AT MORAIYA, AHMEDABAD.  Full Article

Cadila Healthcare's Zydus, ICMR Launch Diagnostic Kits To Detect Rare Infectious Diseases
Wednesday, 29 Nov 2017 

Nov 29 (Reuters) - Cadila Healthcare Ltd ::INDIAN COUNCIL OF MEDICAL RESEARCH, ZYDUS LAUNCH DIAGNOSTIC KITS TO DETECT NEGLECTED INFECTIOUS DISEASES IN LIVESTOCK.SAYS KITS TO BE MADE, MARKETED BY ZYDUS DIAGNOSTICS.  Full Article

Cadila Healthcare says ‍Zydus gets USFDA approval for minocycline hydrochloride extended-release tablets​
Friday, 24 Nov 2017 

Nov 24 (Reuters) - Cadila Healthcare Ltd :Says ‍Zydus receives approval from USFDA for minocycline hydrochloride extended - release tablets.Product to be manufactured at formulations manufacturing facilty at Moraiya, Ahmedabad‍​​.  Full Article

Cadila Healthcare says Zydus gets tentative approval from U.S. FDA for tadalafil tablets USP
Thursday, 23 Nov 2017 

Nov 23 (Reuters) - Cadila Healthcare Ltd :Says Zydus gets tentative approval from USFDA for tadalafil tablets USP.Says drug to be manufactured at group's formulations manufcaturing facility at Moraiya, Ahmedabad.  Full Article

India's Cadila Healthcare Sept-qtr consol profit up about 32 pct
Tuesday, 14 Nov 2017 

Nov 14 (Reuters) - Cadila Healthcare Ltd :Sept quarter consol net profit 5.03 billion rupees versus profit of 3.80 billion rupees last year.Consensus forecast for Sept quarter consol profit was 4.76 billion rupees.Sept quarter consol total revenue from operations 32.34 billion rupees versus 24.04 billion rupees last year.  Full Article

Cadila Healthcare says Zydus gets regulatory nod for lipaglyn (saroglitazar magnesium) ‍​in Mexico
Friday, 10 Nov 2017 

Nov 10 (Reuters) - Cadila Healthcare Ltd :Zydus gets marketing approval from Mexico regulatory authority to commercialize lipaglyn (saroglitazar magnesium)‍​.  Full Article

Cadila Healthcare says Zydus' unit gets U.S. FDA nod for drug used to treat ADHD, narcolepsy
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - Cadila Healthcare Ltd :Zydus' Nesher Pharmaceuticals gets USFDA final approval for dextroamphetamine sulfate and amphetamine sulfate tablets​.  Full Article

Cadila Healthcare says Zydus gets final nod from USFDA for doxycycline hyclate tablets
Tuesday, 31 Oct 2017 

Oct 31 (Reuters) - Cadila Healthcare Ltd :Says ‍zydus receives final approval from USFDA for doxycycline hyclate tablets USP.Says drug to be manufactured at group's formulations manufacturing facility at SEZ, Ahmedabad‍​​.  Full Article

BRIEF-Cadila Healthcare Says ‍Zydus Got USFDA Nod For Two Drugs

* ‍ZYDUS GETS FINAL APPROVAL FROM USFDA FOR PRAMIPEXOLE DIHYDROCHLORIDE EXTENDED-RELEASE TABLETS & NITROFURANTOIN CAPSULES USP (MACROCRYSTALS)​